SGER 0.031    Updated: 07-08-2017 $SGER Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
17
SGER 0.031    Updated: 07-08-2017 $SGER
Last Trade: 6/29/2017
Last 0.031   
Open 0.031
Previous Close 0.031
Day High / Low 0.031 / 0.031
Year High / Low - / -
Volume 2,400
Projected Volume 2400 (26%)
# of Trades / Projected 1 / -
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume ABNORMAL VOLUME
Gap NONE
Candle NEUTRAL
Volatility Today LOW
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 42%
From 80 Day High 25%
From 150 Day High 25%
From 40 Day Low 420%
From 80 Day Low 420%
From 150 Day Low 420%
Pivot Analysis
Price Pivot $ 0.210
Day Resistance 1 $ 0.210
Day Support 1 $ 0.210
Day Resistance 2 $ 0.210
Day Support 2 $ 0.210
Consolidations
Short Term YES
Medium Term YES
Long Term NO
Volume Indicators
20 Day Avg Vol 9,166
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 5,823
Today / 150 Day Avg Vol ABOVE
Abnormal Volume ABNORMAL VOLUME
William Volume Accumulation bearish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics bearish
RSI bearish
MACD bearish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bearish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today LOW
Volatility Index Yesterday MEDIUM
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Scorpius Holdings Boosts Efficiency with New Cost Reduction Plan

Updated Category News Views 183

Scorpius Holdings Implements Significant Cost-Saving Strategies Scorpius Holdings, Inc. (NYSE American: SCPX), a notable player in the biomanufacturing landscape, has recently introduced a series of strategic cost-saving measures. These initiatives aim to reduce operational costs by more than $2 million annually, showcasing the company's commitment to enhancing its...

Continue Reading
McKesson's Strategic Shift: Selling Rexall and Well.ca

Updated Category News Views 122

McKesson Corporation Expands Focus on Healthcare Services IRVING, Texas - McKesson Corporation (NYSE: MCK), a leader in healthcare services with a market capitalization of $72.45 billion and annual revenue exceeding $330 billion, has officially completed the sale of its Rexall and Well.ca businesses to Birch Hill Equity Partners. This noteworthy decision allows McKesson...

Continue Reading
GSI Group Enhances Market with GenesisBPS Acquisition

Updated Category News Views 155

GSI Group Strengthens Its Portfolio GSI Group Holdings has made a significant move by acquiring GenesisBPS, an innovative designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables. This acquisition enhances GSI Group's expanding global sales platform, reinforcing its commitment to serving the life sciences, research and...

Continue Reading
Forecasting Growth in the Antidepressant Drugs Market

Updated Category News Views 156

Understanding the Antidepressant Drugs Market The Antidepressant Drugs Market is anticipated to undergo significant growth, with a projection to reach USD 26.9 billion by 2033. This upward trend reflects a compound annual growth rate (CAGR) of 3.3% from 2024 to 2033, highlighting the increasing reliance on these medications to treat depression. Antidepressants are...

Continue Reading
Inceptio Technology Introduces Strategic Vision for L4 Trucks

Updated Category News Views 227

A Visionary Approach to L4 Autonomous Trucking by Inceptio Technology Inceptio Technology is making significant strides in the field of autonomous trucking, sharing its detailed strategy for scaling Level 4 (L4) autonomous trucks. The company recently took center stage at the Next Truck 2025 conference, demonstrating its commitment to reshaping the future of...

Continue Reading